Invention Grant
- Patent Title: Modulation of nuclear-retained RNA
-
Application No.: US15642709Application Date: 2017-07-06
-
Publication No.: US10526604B2Publication Date: 2020-01-07
- Inventor: C. Frank Bennett , Huynh-Hoa Bui , Kenneth W. Dobie
- Applicant: Ionis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: McNeill Baur PLLC
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N15/113

Abstract:
Provided herein are methods, compounds, and compositions for reducing expression of a nrRNA in an animal. Also provided herein are methods, compounds, and compositions for treating, ameliorating, delaying or reducing a symptom of a disease or disorder associated with a nuclear-retained RNA in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate a disease or condition associated with a nuclear-retained RNA, or a symptom thereof.
Public/Granted literature
- US20180127758A1 MODULATION OF NUCLEAR-RETAINED RNA Public/Granted day:2018-05-10
Information query
IPC分类: